Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Chlamydia Trachomatis | Study Protocol

Exploring causal mechanisms and essential factors in the prevention and control of chlamydia in Guangdong, Southern China: a study protocol

Authors: Wenjun He, Peizhen Zhao, Tao Yang, Yuting Wan, Dadong Wu, Xiaoshan Chen, Zizhen Huang, Huanyuan Luo, Dong (Roman) Xu, Shujie Huang, Cheng Wang

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

Chlamydia Trachomatis (CT) is among the most prevalent sexually transmitted diseases (STDs) globally. According to the World Health Organization, more than 131 million people get infected with CT annually. CT is usually transmitted via sexual contact or perinatal exposure and can result in severe long-term complications. In developing nations, particularly, the prevention and control of CT is challenging. Hence, this study will explore the feedback mechanisms of chlamydia prevention and control, as well as identify the essential factors affecting the control and prevention of this infection in China.

Methods

Our study will employ a mixed-methods research design that encompasses both qualitative and quantitative methods. Firstly, we will develop a causal loop diagram (CLD) based on the literature review and optimize it via in-depth interviews with stakeholders. Additionally, we will utilize a quantitative method called MICMAC(Impact Matrix Cross-Reference Multiplication Applied to a Classification tool) to obtain consensus among different stakeholders and pinpoint the key information. Next, the CLD will be transformed into a system dynamics model (SDM) to evaluate the feedback mechanisms within the CLD. The causality in the CLD will be modeled using mathematical equations, which facilitate the transformation into an SDM. As such, we will be able to analyze the dynamic behavior of the system and its response to different decisions.

Discussion

Our study offers a systematic perspective on the control and prevention of chlamydia infection through system dynamics modeling, examining the dynamic properties and background factors of the system. The creation of the CLD affords stakeholders the chance to comprehend the functionality of their relationships and improve cooperation. Consequently, by evaluating the outcomes of these simulations, it will be possible to analyze and determine potential interventions and their effects on chlamydia infections. This modeling approach can help us gain insight into the dynamic characteristics of the system, evaluate the potential outcomes of different decisions, and design control strategies to either stabilize the system or adjust its behavior.
Literature
1.
go back to reference Newman L, Rowley J, Vander HS et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting [J].2015,10(12): e0143304. Newman L, Rowley J, Vander HS et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting [J].2015,10(12): e0143304.
2.
go back to reference Zhang L, Li W, Tian LS, et al. Cost-effectiveness analysis of screening for chlamydia trachomatis infection in community women in Shenzhen[J]. Chin J AIDS STD. 2021;27(02):155–8. Zhang L, Li W, Tian LS, et al. Cost-effectiveness analysis of screening for chlamydia trachomatis infection in community women in Shenzhen[J]. Chin J AIDS STD. 2021;27(02):155–8.
3.
go back to reference Townshend J. Turner HS.Analysing the effectiveness of Chlamydia screening [J]. J Oper Res Soc 2000,51(7):812–24. Townshend J. Turner HS.Analysing the effectiveness of Chlamydia screening [J]. J Oper Res Soc 2000,51(7):812–24.
4.
go back to reference Evenden D, Harper PR, Brailsford SC et al. Improving the cost-effectiveness of Chlamydia screening with targeted screening strategies[J].System Dynamics: Soft and Hard Operational Research,2018:417–45. Evenden D, Harper PR, Brailsford SC et al. Improving the cost-effectiveness of Chlamydia screening with targeted screening strategies[J].System Dynamics: Soft and Hard Operational Research,2018:417–45.
5.
go back to reference Lan LN, Wu XB, Zhang CL et al. Epidemiological analysis of chlamydia trachomatis infection in Shenzhen from 2008 to 2016[J].Chin J AIDS STD,2021,27(02),155–8. Lan LN, Wu XB, Zhang CL et al. Epidemiological analysis of chlamydia trachomatis infection in Shenzhen from 2008 to 2016[J].Chin J AIDS STD,2021,27(02),155–8.
8.
go back to reference Rowley J, Vander HS,Korenromp E et al. Chlamydia,gonorrhoea,trichomoniasis and syphilis:global prevalence and incidence estimates,2016[J].Bulletin of the World Health Organization,2019,(97):548–62. Rowley J, Vander HS,Korenromp E et al. Chlamydia,gonorrhoea,trichomoniasis and syphilis:global prevalence and incidence estimates,2016[J].Bulletin of the World Health Organization,2019,(97):548–62.
9.
go back to reference Vallely A, Page A,Dias S et al. The prevalence of sexually transmitted infections in Papua New Guinea: a systematic review and meta-analysis[J].PLoS One 2010,5(12):e15586. Vallely A, Page A,Dias S et al. The prevalence of sexually transmitted infections in Papua New Guinea: a systematic review and meta-analysis[J].PLoS One 2010,5(12):e15586.
10.
go back to reference Wang QQ, Liu QZ,XU, JH, et al. Guidelines for clinical diagnosis and control of sexually transmitted diseases. second ed. edition[M].Shanghai Scientific & Technical Publishers; 2020. Wang QQ, Liu QZ,XU, JH, et al. Guidelines for clinical diagnosis and control of sexually transmitted diseases. second ed. edition[M].Shanghai Scientific & Technical Publishers; 2020.
11.
go back to reference Yue XL, Gong XD, Li J et al. Epidemiologic features of genital Chlamydia trachomatis infection at national sexually transmitted disease surveillance sites in China,2015–2019[J].Chin J Dermatology 2020,53(8):596–601. Yue XL, Gong XD, Li J et al. Epidemiologic features of genital Chlamydia trachomatis infection at national sexually transmitted disease surveillance sites in China,2015–2019[J].Chin J Dermatology 2020,53(8):596–601.
12.
go back to reference Owusu-Edusci KJ, Chesson HW, Gif TL et al. The estimated direct medical cost of selected sexually transmitted infections in the United States,2008[J].Sex transm Dis,2013, 40(3):197–201. Owusu-Edusci KJ, Chesson HW, Gif TL et al. The estimated direct medical cost of selected sexually transmitted infections in the United States,2008[J].Sex transm Dis,2013, 40(3):197–201.
13.
go back to reference Force UP. S T.Screening for chlamydial infection; recommendations and rationale[J]. Am J PrevMed. 2001;20(3 Suppl):90–4. Force UP. S T.Screening for chlamydial infection; recommendations and rationale[J]. Am J PrevMed. 2001;20(3 Suppl):90–4.
14.
go back to reference LaMontagne DS, Fenton KA, Randall S, et al. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening[J]. Sex Transm Infect. 2004;80(5):335–41.CrossRefPubMedPubMedCentral LaMontagne DS, Fenton KA, Randall S, et al. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening[J]. Sex Transm Infect. 2004;80(5):335–41.CrossRefPubMedPubMedCentral
15.
go back to reference Australian Department of Health and Ageing. Second national sexually transmissible infections strategy 2010–2013 [R].2010. Australian Department of Health and Ageing. Second national sexually transmissible infections strategy 2010–2013 [R].2010.
16.
go back to reference Public Health Agency Of Canada.Canadian guidelines on sexually transmitted infections[R]2010. Public Health Agency Of Canada.Canadian guidelines on sexually transmitted infections[R]2010.
17.
go back to reference Harder E, Thomsen LT,Frederiksen K, et al. Risk factors for Incident and Redetected Chlamydia trachomatis infection in women: results of a Population-Based cohort Study[J]. Sex Transm Dis. 2016;43(2):113–9.CrossRefPubMed Harder E, Thomsen LT,Frederiksen K, et al. Risk factors for Incident and Redetected Chlamydia trachomatis infection in women: results of a Population-Based cohort Study[J]. Sex Transm Dis. 2016;43(2):113–9.CrossRefPubMed
18.
go back to reference Dhirasasna NN. Sahin O. A multi-methodology approach to creating a causal loop diagram[J]. Syst 2019,7(3):42. Dhirasasna NN. Sahin O. A multi-methodology approach to creating a causal loop diagram[J]. Syst 2019,7(3):42.
19.
go back to reference Ozawas,pongpirulk.10 best resources on… mixed methods research in health systems [J].Health policy and planning,2014,29(3):323-7. Ozawas,pongpirulk.10 best resources on… mixed methods research in health systems [J].Health policy and planning,2014,29(3):323-7.
20.
go back to reference Thompson KM, Tebbens. R J D.Using system dynamics to develop policies that matter: global management of poliomyelitis and beyond[J]. Syst Dynamics Review:The J Syst Dynamics Soc 2008,24(4):433–49. Thompson KM, Tebbens. R J D.Using system dynamics to develop policies that matter: global management of poliomyelitis and beyond[J]. Syst Dynamics Review:The J Syst Dynamics Soc 2008,24(4):433–49.
21.
go back to reference Su Y. Li BZ. A study on system dynamics model of the large-scale enterprise’s original innovation support system[J].Stud Sci Sci,2010(1):141–50. Su Y. Li BZ. A study on system dynamics model of the large-scale enterprise’s original innovation support system[J].Stud Sci Sci,2010(1):141–50.
22.
go back to reference Wang QFSystem. Dynamics(2009 revised Edition)[M]. Shanghai University of Finance & Economics Press; 2009. Wang QFSystem. Dynamics(2009 revised Edition)[M]. Shanghai University of Finance & Economics Press; 2009.
23.
go back to reference Darabi N. Hosseinichimeh N.System dynamics modeling in health and medicine: a systematic literature review[J].Syst Dynamics Rev 2020,36(1):29–73. Darabi N. Hosseinichimeh N.System dynamics modeling in health and medicine: a systematic literature review[J].Syst Dynamics Rev 2020,36(1):29–73.
24.
go back to reference Fathi M, Zeinali M, Torabi M, et al. Structural analysis of the future of iranian online banking employing a MICMAC approach[J]. Technological Forecasting and Social Change; 2022. Fathi M, Zeinali M, Torabi M, et al. Structural analysis of the future of iranian online banking employing a MICMAC approach[J]. Technological Forecasting and Social Change; 2022.
Metadata
Title
Exploring causal mechanisms and essential factors in the prevention and control of chlamydia in Guangdong, Southern China: a study protocol
Authors
Wenjun He
Peizhen Zhao
Tao Yang
Yuting Wan
Dadong Wu
Xiaoshan Chen
Zizhen Huang
Huanyuan Luo
Dong (Roman) Xu
Shujie Huang
Cheng Wang
Publication date
01-12-2023

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine